POLISCOPE
Back to bills
Part ofHealth Care Services →

The civic record

Read. Follow. Verify.
SB 535MONTANASession 2025State BillSigned into law
Enacted

Montana establishes licensing for experimental treatment centers, amends Right to Try Act, and creates insurance premium support account

Original title: Revise laws related to experimental treatments

Last action · May 16, 2025: Chapter Number AssignedSponsor: Kenneth Bogner

Bill progressHistory & official text ↓
Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Does

Montana establishes a mandatory state licensing framework for centers, requiring a $10,000 application fee and $5,000 annual renewal. Licensed centers must allocate 2% of net annual profits to free experimental treatments or an for marketplace health insurance purchasers. The law also protects health care providers from disciplinary action or loss of certification for recommending experimental treatments.

Why it matters

centers face new state fees and profit-allocation rules, while qualifying residents between 139% and 400% of the gain potential access to subsidized health insurance premiums through a newly created state special revenue fund.

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

Experimental treatment centers

Experimental treatment centers must obtain a state license, pay initial and renewal fees, and allocate 2% of their net annual profits to patient access or the insurance premium support account.

Directly affected

Health care providers

Health care providers receive legal protections against licensing board disciplinary actions or loss of Medicare certification solely for recommending or providing experimental treatments.

Directly affected

Qualifying Montana residents

Residents with incomes between 139% and 400% of the federal poverty level purchasing insurance on the federal marketplace may receive health insurance premium support from the new account.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

What is an experimental treatment center under this new law?
An center is a facility that specializes in providing experimental treatments pursuant to Title 50, chapter 12, part 1, and is now subject to state licensing requirements.
How do experimental treatment centers satisfy the health freedom and access requirement?
Centers can fulfill this requirement by providing free to qualifying Montana residents equal to at least 2% of their net annual profits, or by contributing 2% of their net annual profits into the .
Who is eligible for health insurance premium support funded by these centers?
Montana residents who purchase health insurance on the federal health insurance marketplace and have an income between 139% and 400% of the are eligible.
Are a patient's family members responsible for medical debt if a patient dies during an experimental treatment?
No, if a patient dies while being treated with an , the patient's heirs are not liable for any outstanding debt related to the treatment or to a lack of insurance resulting from the treatment.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Follow the record

Votes, people, money & the original source

Where This Stands

Current status: Signed into law.

Procedural history

52 actions
  1. May 16, 2025Senate
    Chapter Number Assigned
  2. May 13, 2025SenateEnrolled
    (S) Signed by Governor
  3. May 5, 2025Senate
    (S) Transmitted to Governor
  4. May 5, 2025House
    (H) Signed by Speaker
  5. May 2, 2025Senate
    (S) Signed by President
  6. Apr 30, 2025Senate
    (S) Returned from Enrolling
Show 46 earlier actions
  1. Apr 29, 2025Senate
    (S) Sent to Enrolling
  2. Apr 29, 2025Senate
    (S) 3rd Reading House Amendments
  3. Apr 29, 2025Senate
    (S) Scheduled for 3rd Reading
  4. Apr 28, 2025Senate
    (S) 2nd Reading House Amendments
  5. Apr 28, 2025Senate
    (S) Scheduled for 2nd Reading
  6. Apr 25, 2025House
    (H) Returned to Senate with Amendments
  7. Apr 25, 2025House
    (H) 3rd Reading
  8. Apr 25, 2025House
    (H) Scheduled for 3rd Reading
  9. Apr 25, 2025House
    (H) Reconsidered Previous Action
  10. Apr 25, 2025House
    (H) 3rd Reading
  11. Apr 25, 2025House
    (H) Scheduled for 3rd Reading
  12. Apr 24, 2025House
    (H) 2nd Reading
  13. Apr 24, 2025House
    (H) Scheduled for 2nd Reading
  14. Apr 22, 2025HouseCommittee
    (H) Committee Report
  15. Apr 22, 2025HouseCommittee
    (H) Committee Executive Action
  16. Apr 12, 2025Senate
    (S) Revised Fiscal Note Printed
  17. Apr 11, 2025Senate
    (S) Fiscal Note Unsigned
  18. Apr 10, 2025Senate
    (S) Revised Fiscal Note Received
  19. Apr 7, 2025House
    (H) Hearing
  20. Apr 7, 2025House
    (H) 1st Reading
  21. Apr 7, 2025Senate
    (S) Revised Fiscal Note Requested
  22. Apr 7, 2025HouseCommittee
    (H) Referred to Committee
  23. Apr 5, 2025Senate
    (S) Transmitted to House
  24. Apr 5, 2025Senate
    (S) 3rd Reading
  25. Apr 5, 2025Senate
    (S) Scheduled for 3rd Reading
  26. Apr 4, 2025Senate
    (S) 2nd Reading
  27. Apr 4, 2025Senate
    (S) Scheduled for 2nd Reading
  28. Apr 3, 2025SenateCommittee
    (S) Committee Report
  29. Apr 2, 2025SenateCommittee
    (S) Committee Executive Action
  30. Mar 28, 2025Senate
    (S) Fiscal Note Printed
  31. Mar 27, 2025Senate
    (S) Fiscal Note Unsigned
  32. Mar 26, 2025Senate
    (S) Fiscal Note Received
  33. Mar 21, 2025Senate
    (S) Hearing
  34. Mar 21, 2025Senate
    (S) Fiscal Note Requested
  35. Mar 21, 2025SenateCommittee
    (S) Referred to Committee
  36. Mar 21, 2025SenateIntroduced
    (S) Introduced
  37. Mar 21, 2025House
    (LC) Draft Delivered to Requester
  38. Mar 20, 2025House
    (LC) Draft Ready for Delivery
  39. Mar 20, 2025House
    (LC) Draft in Assembly
  40. Mar 20, 2025House
    (LC) Draft in Final Drafter Review
  41. Mar 20, 2025House
    (LC) Draft in Input/Proofing
  42. Mar 18, 2025House
    (LC) Draft in Edit
  43. Mar 17, 2025House
    (LC) Draft in Legal Review
  44. Mar 13, 2025House
    (LC) Draft Taken Off Hold
  45. Nov 4, 2024House
    (LC) Draft On Hold
  46. Nov 4, 2024House
    (LC) Drafter Assigned

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Kenneth BognerSenate · District 18RepublicanPrimary sponsor

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift99% confidence

Creation of State-Regulated Experimental Treatment Centers

The legislation integrates experimental treatment providers into the formal state health care facility licensing structure, linking facility profits directly to health insurance premium subsidies.

Department of Public Health and Human Services

Connected Entities

Kenneth Bogner, Department of Public Health and Human Services, Children, Families, Health, and Human Services Interim Committee and 1 more
PersonKenneth Bogner“Republican Senator, District 18, who introduced SB 535”Map →
OrganizationDepartment of Public Health and Human Services“State department responsible for administering the insurance premium support acc”Map →
OrganizationChildren, Families, Health, and Human Services Interim Committee“Legislative interim committee receiving annual reports on the insurance premium ”Map →
OrganizationUnited States Food and Drug Administration“Federal agency regulating drugs, biological products, and medical devices”Map →

Sources

Open source document

bills.legmt.gov

Analysis Score

0–100
  • Significance75
    How much this matters to a regular citizen
  • Controversy45
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz30
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record